These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25038462)

  • 1. Controlled release of sphingosine-1-phosphate agonist with gelatin hydrogels for macrophage recruitment.
    Murakami M; Saito T; Tabata Y
    Acta Biomater; 2014 Nov; 10(11):4723-4729. PubMed ID: 25038462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of mesenchymal stem cells and macrophages by dual release of stromal cell-derived factor-1 and a macrophage recruitment agent enhances wound closure.
    Kim YH; Tabata Y
    J Biomed Mater Res A; 2016 Apr; 104(4):942-56. PubMed ID: 26704185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels.
    Kim YH; Furuya H; Tabata Y
    Biomaterials; 2014 Jan; 35(1):214-24. PubMed ID: 24125774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of fibrin hydrogels to promote the recruitment of anti-inflammatory macrophages.
    Tanaka R; Saito Y; Fujiwara Y; Jo JI; Tabata Y
    Acta Biomater; 2019 Apr; 89():152-165. PubMed ID: 30862554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration.
    Tanigo T; Takaoka R; Tabata Y
    J Control Release; 2010 Apr; 143(2):201-6. PubMed ID: 20060429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of wound closure by modifying dual release patterns of stromal-derived cell factor-1 and a macrophage recruitment agent from gelatin hydrogels.
    Kim YH; Tabata Y
    J Tissue Eng Regen Med; 2017 Nov; 11(11):2999-3013. PubMed ID: 27696699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective sphingosine-1-phosphate receptor 1 agonist SEW-2871 aggravates gastric cancer by recruiting myeloid-derived suppressor cells.
    Zhou Y; Guo F
    J Biochem; 2018 Jan; 163(1):77-83. PubMed ID: 29036438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy.
    Saito T; Tabata Y
    Acta Biomater; 2012 Feb; 8(2):646-52. PubMed ID: 22079782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities.
    Tabata Y; Ikada Y
    Biomaterials; 1999 Nov; 20(22):2169-75. PubMed ID: 10555085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vascular patch prepared from Thai silk fibroin and gelatin hydrogel incorporating simvastatin-micelles to recruit endothelial progenitor cells.
    Thitiwuthikiat P; Ii M; Saito T; Asahi M; Kanokpanont S; Tabata Y
    Tissue Eng Part A; 2015 Apr; 21(7-8):1309-19. PubMed ID: 25517108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ceramide and SEW 2871 in the transcription of enzymes involved in amyloid b precursor protein metabolism in an experimental model of Alzheimer's disease.
    Czubowicz K; Wójtowicz S; Wencel PL; Strosznajder RP
    Folia Neuropathol; 2018; 56(3):196-205. PubMed ID: 30509041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of bone regeneration following the controlled release of water-insoluble oxysterol from biodegradable hydrogel.
    Hokugo A; Saito T; Li A; Sato K; Tabata Y; Jarrahy R
    Biomaterials; 2014 Jul; 35(21):5565-71. PubMed ID: 24731715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of simvastatin from biodegradable hydrogels promotes odontoblastic differentiation.
    Miyazawa A; Matsuno T; Asano K; Tabata Y; Satoh T
    Dent Mater J; 2015; 34(4):466-74. PubMed ID: 26235711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone regeneration by lactoferrin released from a gelatin hydrogel.
    Takaoka R; Hikasa Y; Hayashi K; Tabata Y
    J Biomater Sci Polym Ed; 2011; 22(12):1581-9. PubMed ID: 20663279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel.
    Konishi M; Tabata Y; Kariya M; Suzuki A; Mandai M; Nanbu K; Takakura K; Fujii S
    J Control Release; 2003 Oct; 92(3):301-13. PubMed ID: 14568411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local release of pioglitazone (a peroxisome proliferator-activated receptor γ agonist) accelerates proliferation and remodeling phases of wound healing.
    Sakai S; Sato K; Tabata Y; Kishi K
    Wound Repair Regen; 2016; 24(1):57-64. PubMed ID: 26710090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel.
    Yamamoto M; Tabata Y; Hong L; Miyamoto S; Hashimoto N; Ikada Y
    J Control Release; 2000 Feb; 64(1-3):133-42. PubMed ID: 10640652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local suppression of pro-inflammatory cytokines and the effects in BMP-2-induced bone regeneration.
    Ratanavaraporn J; Furuya H; Tabata Y
    Biomaterials; 2012 Jan; 33(1):304-16. PubMed ID: 22019155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis.
    Kimura Y; Tabata Y
    J Biomater Sci Polym Ed; 2010; 21(1):37-51. PubMed ID: 20040152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation.
    Ozeki M; Ishii T; Hirano Y; Tabata Y
    J Drug Target; 2001; 9(6):461-71. PubMed ID: 11822818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.